Adolescent Childbirth and Mobility Disability Among Women Ages 15-49: An Analysis of Population Health Surveys from 14 Low- and Middle-Income Countries

2021 ◽  
Author(s):  
Katherine E. Peck ◽  
Diego Bassani ◽  
Saionara MA Câmara ◽  
Marlos R. Domingues ◽  
Tetine Sentell ◽  
...  
2019 ◽  
Vol 12 (5) ◽  
pp. 388-394
Author(s):  
Emmanuel O Adewuyi ◽  
Asa Auta

Abstract Background Unsafe injection practices contribute to increased risks of blood-borne infections, including human immunodeficiency virus, hepatitis B and hepatitis C viruses. The aim of this study was to estimate the prevalence of medical injections as well as assess the level of access to sterile injection equipment by demographic factors in low- and middle-income countries (LMICs). Methods We carried out a meta-analysis of nationally representative Demographic and Health Surveys (DHSs) conducted between 2010 and 2017 in 39 LMICs. Random effects meta-analysis was used in estimating pooled and disaggregated prevalence. All analyses were conducted using Stata version 14 and Microsoft Excel 2016. Results The pooled 12-month prevalence estimate of medical injection was 32.4% (95% confidence interval 29.3–35.6). Pakistan, Rwanda and Myanmar had the highest prevalence of medical injection: 59.1%, 56.4% and 53.0%, respectively. Regionally, the prevalence of medical injection ranged from 13.5% in west Asia to 42.7% in south and southeast Asia. The pooled prevalence of access to sterile injection equipment was 96.5%, with Pakistan, Comoros and Afghanistan having comparatively less prevalence: 86.0%, 90.3% and 90.9%, respectively. Conclusions Overuse of medical injection and potentially unsafe injection practices remain a considerable challenge in LMICs. To stem the tides of these challenges, national governments of LMICs need to initiate appropriate interventions, including education of stakeholders, and equity in access to quality healthcare services.


2019 ◽  
Vol 9 (2) ◽  
Author(s):  
Saverio Bellizzi ◽  
Alessandra Nivoli ◽  
Paola Salaris ◽  
Anna Rita Ronzoni ◽  
Giuseppe Pichierri ◽  
...  

Author(s):  
Ijeoma Peace Edoka

Low- and middle-income countries (LMICs) bear a disproportionately high burden of diseases in comparison to high-income countries, partly due to inequalities in the distribution of resources for health. Recent increases in health spending in these countries demonstrate a commitment to tackling the high burden of disease. However, evidence on the extent to which increased spending on health translates to better population health outcomes has been inconclusive. Some studies have reported improvements in population health with an increase in health spending whereas others have either found no effect or very limited effect to justify increased financial allocations to health. Differences across studies may be explained by differences in approaches adopted in estimating returns to health spending in LMICs.


Sign in / Sign up

Export Citation Format

Share Document